GENE THERAPY COMPANIES

Nucleome Informatics launches gene test for detecting inherited retinal diseases

DrSeq IRD panel helps identify the genetic mutations responsible for specific IRD types, enabling patients to qualify for clinical trials or access targeted treatments tailored to their genetic profiles. One unique aspect of the test is its saliva-based collection method, which eliminates the need for blood samples, stated Nucleome.